Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
about
Xenobiotic and Endobiotic Mediated Interactions Between the Cytochrome P450 System and the Inflammatory Response in the LiverNew genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivityIdiosyncratic adverse drug reactions: current conceptsEvidence for cellular protein covalent binding derived from styrene metaboliteElevated levels of antibodies against xenobiotics in a subgroup of healthy subjectsLiver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane.CYP2E1 immunoglobulin G4 subclass antibodies after desflurane anesthesia.Mitochondria-targeted cytochrome P450 2E1 induces oxidative damage and augments alcohol-mediated oxidative stress.Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis.Xenobiotic exposure and autoimmune hepatitisLiver cell models in in vitro toxicology.CYP2E1 and oxidative liver injury by alcohol.Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies.Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury: a reviewRepeated exposure to modern volatile anaesthetics may cause chronic hepatitis as well as acute liver injuryPathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.Proteasome inhibition compromises direct retention of cytochrome P450 2C2 in the endoplasmic reticulum.Suppressive and pro-inflammatory roles for IL-4 in the pathogenesis of experimental drug-induced liver injury.Trifluoroacetylated IgG4 antibodies in a child with idiosyncratic acute liver failure after first exposure to halothane.CYP2E1 autoantibodies in liver diseasesHepatic cytochromes P450: structural degrons and barcodes, posttranslational modifications and cellular adapters in the ERAD-endgame.Oxidative stress and antioxidants in hepatic pathogenesis.Identification of a Shared Cytochrome p4502E1 Epitope Found in Anesthetic Drug-Induced and Viral Hepatitis
P2860
Q26800213-EF886A51-8A4D-4818-BEB5-EBF1CFC081C7Q26800976-F873E4FD-0D5D-4FA8-9F91-83E17C96894DQ26824391-F61F5E89-275C-40E1-AA3A-70369E8A4B4FQ28389307-739ECA84-3591-46F1-A33E-51869B7B69A0Q28390156-A778B40E-964C-4471-AC42-982C9DEC01C7Q30846833-0CE04BA1-065B-4D71-A789-4A0EBD49C015Q33660042-A18090DF-4566-42C2-A1AD-0FA011E64DD5Q34042602-2AA365F9-F7AC-418C-87E6-E78424FDF529Q34429256-A6DC33AC-9F5D-4A4B-8D26-68AEC180628DQ34495354-050AE026-9D30-45EF-B027-4CADC071C2EDQ34941510-B651FEB1-8249-497C-AE39-1713263015CEQ36498699-F6030E6E-B4DE-4139-AABC-DD68A3146C24Q36831954-C254E916-84CA-4566-AEC3-A7A5D2BE7B96Q36851882-3490D07A-94E9-46E0-8B44-0FA798DAF334Q36884643-6FBC9C23-5F94-4D4A-AC4C-5D73D8C350B9Q36926122-CABC2E5D-D0DB-4E53-B9B1-1A7AE9B3033CQ37076631-81B2D9AD-7150-4492-81B7-F529C35726AAQ37332780-141CFF9C-6A96-43AD-ACC7-2EC8429D8CF3Q37352159-63600B05-D4CE-4838-8B88-50B770DDAA62Q38280871-4FACD02D-296E-4290-BCAF-5862B922A1FBQ41666716-30E46883-690D-4F48-9269-8B0AE7D643CCQ42558183-E4073000-7E59-4AF3-B267-C834E49EAB8EQ57285391-16F11D63-155E-4D97-87D8-F3849561435B
P2860
Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
@en
type
label
Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
@en
prefLabel
Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
@en
P1476
Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis
@en
P2093
P304
P577
1996-09-01T00:00:00Z